These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 38140900)
21. Plexiform neurofibroma of the tongue: a case report of a child. Güneri EA; Akoğlu E; Sütay S; Ceryan K; Sağol O; Pabuçcuoğlu U Turk J Pediatr; 2006; 48(2):155-8. PubMed ID: 16848118 [TBL] [Abstract][Full Text] [Related]
22. Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas. Dombi E; Baldwin A; Marcus LJ; Fisher MJ; Weiss B; Kim A; Whitcomb P; Martin S; Aschbacher-Smith LE; Rizvi TA; Wu J; Ershler R; Wolters P; Therrien J; Glod J; Belasco JB; Schorry E; Brofferio A; Starosta AJ; Gillespie A; Doyle AL; Ratner N; Widemann BC N Engl J Med; 2016 Dec; 375(26):2550-2560. PubMed ID: 28029918 [TBL] [Abstract][Full Text] [Related]
23. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey. Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219 [TBL] [Abstract][Full Text] [Related]
24. Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care. Avery RA; Katowitz JA; Fisher MJ; Heidary G; Dombi E; Packer RJ; Widemann BC; Ophthalmology; 2017 Jan; 124(1):123-132. PubMed ID: 27817916 [TBL] [Abstract][Full Text] [Related]
25. Plexiform neurofibroma: shedding light on the investigational agents in clinical trials. Acar S; Armstrong AE; Hirbe AC Expert Opin Investig Drugs; 2022 Jan; 31(1):31-40. PubMed ID: 34932916 [TBL] [Abstract][Full Text] [Related]
26. Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials. Cannon A; Sarin KY; Petersen AK; Pichard DC; Wolters PL; Erickson G; Lessing AJ; Li P; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR Clin Trials; 2024 Feb; 21(1):67-72. PubMed ID: 37269078 [TBL] [Abstract][Full Text] [Related]
27. A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas. Anderson MK; Johnson M; Thornburg L; Halford Z Ann Pharmacother; 2022 Jun; 56(6):716-726. PubMed ID: 34541874 [TBL] [Abstract][Full Text] [Related]
28. Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life. Wolters PL; Burns KM; Martin S; Baldwin A; Dombi E; Toledo-Tamula MA; Dudley WN; Gillespie A; Widemann BC Am J Med Genet A; 2015 Sep; 167A(9):2103-13. PubMed ID: 25976979 [TBL] [Abstract][Full Text] [Related]
29. Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1. Gross AM; Plotkin SR; Watts NB; Fisher MJ; Klesse LJ; Lessing AJ; McManus ML; Larson AN; Oberlander B; Rios JJ; Sarnoff H; Simpson BN; Ullrich NJ; Stevenson DA Clin Trials; 2024 Feb; 21(1):29-39. PubMed ID: 37772407 [TBL] [Abstract][Full Text] [Related]
30. Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials. Thompson HL; Blanton A; Franklin B; Merker VL; Franck KH; Welling DB; Neurology; 2021 Aug; 97(7 Suppl 1):S64-S72. PubMed ID: 34230203 [TBL] [Abstract][Full Text] [Related]
31. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas. Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379 [TBL] [Abstract][Full Text] [Related]
32. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials. Sundby RT; Rhodes SD; Komlodi-Pasztor E; Sarnoff H; Grasso V; Upadhyaya M; Kim A; Evans DG; Blakeley JO; Hanemann CO; Bettegowda C Clin Trials; 2024 Feb; 21(1):40-50. PubMed ID: 37904489 [TBL] [Abstract][Full Text] [Related]
33. [Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma]. Reschke R; Kadlecova M; Grunewald S; Ziemer M Hautarzt; 2019 Aug; 70(8):638-640. PubMed ID: 31076816 [TBL] [Abstract][Full Text] [Related]
34. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1. Jett K; Nguyen R; Arman D; Birch P; Chohan H; Farschtschi S; Fuensterer C; Kluwe L; Friedman JM; Mautner VF Am J Med Genet A; 2015 Jul; 167(7):1518-24. PubMed ID: 25900062 [TBL] [Abstract][Full Text] [Related]
35. Growth behavior of plexiform neurofibromas after surgery. Nguyen R; Ibrahim C; Friedrich RE; Westphal M; Schuhmann M; Mautner VF Genet Med; 2013 Sep; 15(9):691-7. PubMed ID: 23598713 [TBL] [Abstract][Full Text] [Related]
36. Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas. Gross AM; Dombi E; Wolters PL; Baldwin A; Dufek A; Herrera K; Martin S; Derdak J; Heisey KS; Whitcomb PM; Steinberg SM; Venzon DJ; Fisher MJ; Kim A; Bornhorst M; Weiss BD; Blakeley JO; Smith MA; Widemann BC Neuro Oncol; 2023 Oct; 25(10):1883-1894. PubMed ID: 37115514 [TBL] [Abstract][Full Text] [Related]